Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

Dupilumab treatment of atopic dermatitis resulted in long-term skin improvements linked to changes in skin’s the molecular composition.

Netherlands: A recent real-world, long-term study from the BioDay Registry has highlighted a significant incidence of ...

Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...

A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis, highlighting a need for ophthalmologic monitoring in youth.

Underlying social and economic barriers in the U.S. may play a significant role in the higher rates of atopic dermatitis.

crisaborole (a topical ointment), and dupilumab (a biologic) than white patients. It’s not clear what factors play the biggest role in this discrepancy, but the researchers suggested that doctor ...

Connect Biopharma (CNTB) announced the online publication of results from the global Phase 2 trial of rademikibart in patients with ...

Benralizumab can cause mild side effects like headache or sore throat. Dupilumab also treats severe eosinophilic asthma. It is an injection that can be taken at home, although a doctor may give ...